[CEA test in domestic animals].

The researchers have studied the use of a CEA (carcino embryonic antigen) test, generally used for humans, on animals and have found it to be a useful diagnostic tool. They’ve determined upper limits for dogs, cats, cows, sheep, and horses.

Overview of the CEA Test and Its Traditional Use

• The carcino embryonic antigen (CEA) test is commonly used in cancer diagnosis and follow-up in humans. Despite its low sensitivity and specificity, meaning it can often give false positives or negatives, it is a standard procedure.
• Traditionally, the CEA test uses polyclonal antibodies, which can bind to multiple sites on any single antigen, making the results broad and non-specific. This has proved to be inadequate when testing animal sera, the liquid fraction of blood that doesn’t involve clotting factors.

Application of Monoclonal CEA Tests Designed for Human Sera

• The researchers have examined the applicability of a recently designed CEA test that makes use of monoclonal antibodies instead. Monoclonal antibodies have the advantage of binding to only one specific site, making the results more definitive and reliable.
• While the test was initially designed for human sera, the researchers applied it to animal sera to evaluate its efficacy. They found this newly designed CEA test was of supplemental diagnostic value when used with animals.

Upper Normal Limit for Different Animals

• The researchers were able to determine an upper normal limit value for the CEA in various animals. This could facilitate diagnosis of diseases in these animals, particularly various forms of cancer.
• For dogs, the upper normal limit was found to be 1.65 ng/ml. For cats, it was 2.81 ng/ml. For cows and sheep, the upper normal limit was the same at 2.85 ng/ml, and for horses, it was 1.61 ng/ml.
• These values could serve as quick reference points when testing pet or farm animals, providing veterinarians with an additional tool for diagnosis.